Olema Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.09 billion, with shareholders equity totaling $430.56 million.
The company employs approximately 37 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, Olema Pharmaceuticals Inc. reported $- in revenue, generating net income of $-204.57 million.
Key financial metrics include a P/E ratio of -5.32, a price-to-book (P/B) ratio of 2.53, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker OLMA.